project id: TCGA-SKCM; case submitter id: TCGA-BF-A3DN; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.3; age at index: 81; days to birth: -29801; ethnicity: hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1930; age at diagnosis: 29801; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 717.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 177; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-BF-A3DN-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 85.0;